Source study found

Story checked

Men with lower testosterone at 31 reported good health 15 years later (opens in a new tab)

news-medical.net · 2026-10-27

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

3 supported
1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Men with lower testosterone at 31 reported good health 15 years later

news-medical.net · 2026-10-27

The story’s checkable claims.

Read the original story

NewsLink checks it

Mostly supported

Every claim we could check holds up. Three of four claims match the study. This overall rating is based only on the claims we could check. One claim the study doesn't address.

3 supported
1 not covered

Open claim evidence

The source study

Associations Between Testosterone Levels in Men at Age 31 and Quality of Life, Self-Reported Health, and Morbidity at Age 46: The Northern Finland Birth Cohort 1966

Endocrine Connections · 2026

Open source record Open in Tessa

Source paper

Source layer

The 3 papers the story cites

Source study separated from background citations.

The research anchor for the report.

The study this story reportsmentioned without context
Associations Between Testosterone Levels in Men at Age 31 and Quality of Life, Self-Reported Health, and Morbidity at Age 46: The Northern Finland Birth Cohort 1966
Endocrine Connections · 2026
PubMed (opens in a new tab)Full Tessa analysis (opens in a new tab)
The study this story reportsmentioned without context
10.1530/ec-26-0523/78418/associations-between-testosterone-levels-in-men-at
Publisher (opens in a new tab)
The study this story reportspresented as the new finding
Associations Between Testosterone Levels in Men at Age 31 and Quality of Life, Self-Reported Health, and Morbidity at Age 46: The Northern Finland Birth Cohort 1966
Where the story links (opens in a new tab)

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredMen in the lowest testosterone quartile generally reported good health and excellent quality of life in middle age, and the article says higher odds of some conditions and lower sexual activity scores were no longer statistically significant after adjustment for waist circumference.View evidenceHide evidence

As statedapproximately 0.01 points difference in unadjusted mean 15D scores

Why this verdict

The main qualitative points are supported by the abstract-level profile: QoL was excellent across quartiles, and unadjusted differences in sexual activity and metabolic/gastrointestinal disease were no longer significant after adjustment for waist circumference. However, the stated quantitative detail of an approximately 0.01-point unadjusted mean 15D score difference is not available in the abstract-level profile, which explicitly lacks effect-size details.

Study evidence

No significant differences in self-reported health status at age 46 were observed across testosterone quartiles measured at age 31.

“The study population was a population-based cohort comprising men born in Northern Finland in 1966.”

Study evidence

No significant differences in overall self-reported health at age 46 were observed across testosterone quartiles measured at age 31.

“We investigated self-reported health status, comorbidity, and quality of life (QoL) in men at age 46 across testosterone (T) quartiles at age 31”

Claim 2 of 4SupportedResearchers reported that testosterone concentrations at age 31 were not associated with substantial differences in self-reported health or quality of life at age 46.View evidenceHide evidence

Why this verdict

The headline claim is broadly consistent with the abstract: no significant differences in self-reported health were observed across testosterone quartiles, and the authors concluded there were no marked/notable differences in self-reported health or quality of life. The headline does simplify the nuance that adjusted models showed slightly better QoL in the lowest testosterone quartile versus the highest, but the story’s wording says no substantial differences rather than no differences at all.

Study evidence

No significant differences in self-reported health status at age 46 were observed across testosterone quartiles measured at age 31.

“The study population was a population-based cohort comprising men born in Northern Finland in 1966.”

Study evidence

No significant differences in overall self-reported health at age 46 were observed across testosterone quartiles measured at age 31.

“We investigated self-reported health status, comorbidity, and quality of life (QoL) in men at age 46 across testosterone (T) quartiles at age 31”

Claim 3 of 4SupportedA 15-year Finnish birth cohort study examined how testosterone levels at age 31 related to metabolic disease, mood, sexual activity, and quality of life at age 46.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that this was a Northern Finland Birth Cohort 1966 prospective analysis measuring testosterone at age 31 and assessing age-46 outcomes including metabolic disease, depression/mood-related outcomes, sexual activity, self-reported health, and 15D quality of life.

Study evidence

No significant differences in self-reported health status at age 46 were observed across testosterone quartiles measured at age 31.

“The study population was a population-based cohort comprising men born in Northern Finland in 1966.”

Study evidence

No significant differences in overall self-reported health at age 46 were observed across testosterone quartiles measured at age 31.

“We investigated self-reported health status, comorbidity, and quality of life (QoL) in men at age 46 across testosterone (T) quartiles at age 31”

Claim 4 of 4SupportedThe article cautions that the findings do not establish causality and may not apply beyond this Finnish cohort.View evidenceHide evidence

Why this verdict

The profile identifies an observational cohort design, inability to establish causality, and limited generalizability because the study population was men from a single Northern Finland birth cohort. The story’s caveat matches those limitations.

Study evidence

No significant differences in overall self-reported health at age 46 were observed across testosterone quartiles measured at age 31.

“We investigated self-reported health status, comorbidity, and quality of life (QoL) in men at age 46 across testosterone (T) quartiles at age 31”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

Contextual group differences: men in the lowest testosterone quartile were more obese, less likely to smoke, and consumed less alcohol than men in the highest quartile.
The story mentions adjustment for waist circumference and other factors but does not specifically report these descriptive differences across testosterone quartiles, which are relevant for interpreting confounding.
From Population-based cohort descriptive comparisons across testosterone quartiles

7 things the story did carry across

Population and design: population-based prospective cohort of Northern Finland Birth Cohort 1966 men, with testosterone measured at age 31 and outcomes assessed at age 46.
Primary exposure definition: serum testosterone at age 31 was categorized into quartiles, including comparison of lowest versus highest quartiles.
Main health/QoL finding: no significant differences in self-reported health across testosterone quartiles; overall 15D quality of life was excellent across groups, with only a slight adjusted QoL difference favoring the lowest testosterone quartile.
Morbidity and sexual activity findings: unadjusted differences were seen for substance use disorders, depression, sexual activity, metabolic disease, and gastrointestinal disease; after adjustment for waist circumference, sexual activity and metabolic/gastrointestinal disease differences were no longer significant.
Limitation: observational design means the study cannot establish causality.
Limitation: outcomes were self-reported survey measures, including comorbidity, mental health, substance use, sexual activity, and quality of life.
Limitation: generalizability may be limited because the study population was men from a single Northern Finland birth cohort born in 1966.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoAssess whether serum testosterone levels at age 31 predict later self-reported health status and quality of life at age 46 in men from the Northern Finland Birth Cohort 1966 (including adjustment for waist circumference).prospective cohortExpand

In plain English

Prospective analysis in men from the Northern Finland Birth Cohort 1966 (n=2691) relating serum testosterone measured at age 31 (categorized into quartiles) to self-reported health, comorbidity, and quality of life (15D questionnaire) at age 46. Overall there were no notable differences in self-rated health across testosterone quartiles; some unadjusted differences in morbidity and behaviours were observed between the lowest and highest T quartiles but many differences attenuated after adjustment for waist circumference. Overall QoL was high across groups and was slightly better in the lowest vs highest T quartile in adjusted models (p=0.02).

Key findings

No significant differences in self-reported health status at age 46 were observed across testosterone quartiles measured at age 31.
Overall QoL (15D) was excellent across all quartiles; adjusted analyses indicated slightly better QoL in the lowest T quartile (Q1) compared with the highest (Q4) (p=0.02).

“The study population was a population-based cohort comprising men born in Northern Finland in 1966.”

2human in vivoAssess whether serum testosterone levels at age 31 predict later morbidity/comorbidity profiles (self-reported medical conditions/mental health/substance use/sexual activity) at age 46 in the same cohort (including adjustment for waist circumference).population-based prospective cohortExpand

In plain English

In a prospective analysis of 2,691 men from the Northern Finland Birth Cohort 1966, serum testosterone measured at age 31 (categorized into quartiles) was compared with self-reported morbidity/comorbidity outcomes at age 46. Unadjusted comparisons showed several differences between the lowest and highest T quartiles (substance use disorders, depression, sexual activity, metabolic and gastrointestinal disease), but many of these differences were attenuated after adjustment for waist circumference; overall self-reported health and quality-of-life were generally similar across quartiles.

Key findings

No significant differences in overall self-reported health at age 46 were observed across testosterone quartiles measured at age 31.
Men in the lowest testosterone quartile (Q1) differed from those in the highest quartile (Q4): they were more obese, less likely to smoke, and consumed less alcohol (p<0.001 for these comparisons).

“We investigated self-reported health status, comorbidity, and quality of life (QoL) in men at age 46 across testosterone (T) quartiles at age 31”

What this piece can’t prove

Observational cohort design: potential for residual confounding and inability to establish causality.
Abstract provides limited detail on covariates beyond waist circumference and does not report effect estimates or confidence intervals.
Study population is men from a single birth cohort in Northern Finland (born 1966), which may limit generalizability to other populations or age cohorts.
Exposure categorized into quartiles may obscure dose–response relationships and reduces exposure granularity; effect sizes not reported in abstract.

1 further detail could not be confirmed from the summary.

3human in vivoDescribe baseline/age-31-to-46 group characteristics across testosterone quartiles (e.g., obesity, smoking, alcohol) to contextualize quartile comparisons and potential confounding.Population-based cohort descriptive comparisons across testosterone quartilesExpand

In plain English

Descriptive comparison of baseline characteristics across testosterone quartiles in a population-based cohort of men born in 1966 (measured at age 31). The lowest T quartile (Q1) showed higher obesity prevalence and lower smoking and alcohol consumption than the highest T quartile (Q4); differences were reported with p-values (p<0.001). Quartile sizes and T cutpoints were reported.

Key findings

Men in the lowest testosterone quartile at age 31 (Q1) were more obese, less likely to smoke, and consumed less alcohol than men in the highest quartile (Q4).
Quartile sample sizes and T cutpoints were reported: Q1 n=660, Q2 n=681, Q3 n=664, Q4 n=686; quartile cutpoints: Q1<17.2, Q2=17.2–20.99, Q3=21.0–25.49, Q4≥25.5 nmol/L.

“Men in Q1 were more obese, less likely to smoke, and consumed less alcohol compared to men in Q4”

What this piece can’t prove

Abstract provides limited methodological detail on how obesity, smoking, and alcohol consumption were measured (self-report vs. measured) and which statistical tests were used.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer